02/23/2021
4:17 PM | Esperion Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/23/2021
4:15 PM | Esperion Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/23/2021
3:15 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2021
12:03 PM | Esperion Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/09/2021
1:56 PM | Esperion Therapeutics (Subject)
WASATCH ADVISORS INC (Filed by)
| Form SC 13G/A
| |
01/29/2021
4:01 PM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2021
4:01 PM | Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2021
4:01 PM | Esperion Therapeutics (Issuer)
Hall Ashley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2021
4:00 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2021
6:00 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
01/06/2021
1:37 PM | Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
| Form SC 13G/A
| |
12/31/2020
3:09 PM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2020
6:36 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2020
6:48 AM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/15/2020
6:32 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2020
1:36 PM | Esperion Therapeutics (Subject)
WASATCH ADVISORS INC (Filed by)
| Form SC 13G
| |
11/16/2020
4:15 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2020
6:01 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2020
3:37 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2020
4:21 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2020
3:28 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2020
4:18 PM | Esperion Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/10/2020
4:16 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/22/2020
7:00 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2020
3:44 PM | Esperion Therapeutics (Subject)
MARSHALL WACE, LLP (Filed by)
| Form SC 13G
| |
05/29/2020
3:42 PM | Berkowitz Jeffrey (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2020
3:41 PM | Esperion Therapeutics (Issuer)
Fuhrman Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2020
3:32 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2020
4:26 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/20/2020
7:01 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2020
9:34 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/06/2020
6:15 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2020
7:07 AM | Esperion Therapeutics (Issuer)
Fuhrman Alan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/18/2020
7:00 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2020
6:34 AM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2020
5:16 AM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2020
6:30 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2020
4:12 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2020
11:51 AM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2020
7:23 AM | Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
| Form SC 13G/A
| |
01/03/2020
3:27 PM | Esperion Therapeutics (Issuer)
Glickman Mark A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
3:27 PM | Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
3:27 PM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2019
1:54 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2019
3:30 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2019
7:30 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2019
3:22 PM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2019
3:09 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2019
3:30 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2019
3:32 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2019
7:00 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2019
11:42 AM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2019
3:57 PM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2019
4:18 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2019
5:09 PM | Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:52 PM | Esperion Therapeutics (Issuer)
Woody Tracy M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:52 PM | Braunstein Scott (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:52 PM | Berkowitz Jeffrey (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:51 PM | Esperion Therapeutics (Issuer)
JANNEY DANIEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:51 PM | Esperion Therapeutics (Issuer)
GOTTO ANTONIO M JR MD D PHIL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:50 PM | Esperion Therapeutics (Issuer)
MCGOVERN MARK E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:50 PM | Esperion Therapeutics (Issuer)
Shepard Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:49 PM | Esperion Therapeutics (Issuer)
Woody Tracy M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/30/2019
3:32 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2019
3:30 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2019
3:32 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2019
7:01 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2019
3:30 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2019
3:32 PM | Esperion Therapeutics (Filer)
| Form DEF 14A
| |
04/05/2019
4:23 PM | Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2019
3:41 PM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2019
4:01 PM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2019
8:02 AM | Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2019
6:50 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2019
3:57 PM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2019
3:57 PM | Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2019
3:50 PM | Esperion Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2019
3:45 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2019
4:22 PM | Esperion Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
| Form SC 13G/A
| |
02/14/2019
3:30 PM | Esperion Therapeutics (Subject)
Pentwater Capital Management LP (Filed by)
| Form SC 13G/A
| |
02/14/2019
10:16 AM | Esperion Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/11/2019
1:17 PM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G
| |
01/07/2019
4:10 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2019
6:45 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2019
9:57 AM | Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
| Form SC 13G/A
| |
12/26/2018
10:44 AM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
4:07 PM | Esperion Therapeutics (Issuer)
Glickman Mark A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/21/2018
4:03 PM | Esperion Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/21/2018
4:03 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2018
12:14 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
4:18 PM | Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
4:17 PM | Esperion Therapeutics (Issuer)
Lalwani Narendra D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
4:15 PM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2018
6:56 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Esperion Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2018
4:00 PM | Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2018
3:20 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2018
3:35 PM | Boxer Capital, LLC (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A
| |
10/30/2018
3:33 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Braslyn Ltd. (Reporting)
Esperion Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
Tuesday Thirteen Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/29/2018
6:45 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2018
4:05 PM | Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
